Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome

Objectives Obstetric antiphospholipid syndrome (OAPS) is an autoimmune disease characterised by the presence of antiphospholipid antibodies in circulation and pathological pregnancy. However, the pathogenesis of OAPS remains unknown. We aimed to reveal cellular compositions and molecular features of decidual cells involved in the development of OAPS using single-cell RNA sequencing (scRNA-seq). Methods We performed unbiased scRNA-seq analysis on the first-trimester decidua from five OAPS patients and five healthy controls (HCs), followed by validations with flow cytometry, immunohistochemical staining and immunofluorescence in a larger cohort. Serum chemokines and cytokines were measured by using ELISA. Results A higher ratio of macrophages but a lower ratio of decidual natural killer (dNK) cells was found in decidua from OAPS compared with HCs. Vascular endothelial cells shrinked in OAPS decidua while having upregulated chemokine expression and conspicuous responses to IFN-γ and TNF-α. Macrophages in OAPS had stronger phagocytosis function, complement activation signals and relied more on glycolysis. dNK cells were more activated in OAPS and had enhanced cytotoxicity and IFN-γ production. Downregulation of granules in OAPS dNK cells could be associated with suppressed glycolysis. Moreover, stromal cells had a prosenescent state with weakened immune surveillance for senescent cells in OAPS. In addition, the cellular interactions between decidual immune cells and those of immune cells with non-immune cells under disease state were altered, especially through chemokines, IFN-γ and TNF-α. Conclusion This study provided a comprehensive decidual cell landscape and identified aberrant decidual microenvironment in OAPS, providing some potential therapeutic targets for this disease.

[1]  Chengde Yang,et al.  Correspondence on ‘2023 ACR/EULAR antiphospholipid syndrome classification criteria’ , 2023, Annals of the Rheumatic Diseases.

[2]  R. Levy,et al.  2023 ACR/EULAR antiphospholipid syndrome classification criteria , 2023, Arthritis & Rheumatology.

[3]  J. Ernerudh,et al.  The human placenta shapes the phenotype of decidual macrophages , 2022, bioRxiv.

[4]  M. López-Hoyos,et al.  Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis , 2022, Lupus.

[5]  M. Tong,et al.  Antiphospholipid Antibodies Increase Endometrial Stromal Cell Decidualization, Senescence, and Inflammation via Toll‐like Receptor 4, Reactive Oxygen Species, and p38 MAPK Signaling , 2022, Arthritis & rheumatology.

[6]  M. Rojas,et al.  Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome , 2021, Frontiers in Physiology.

[7]  F. Rubinstein,et al.  The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. , 2021, Thrombosis research.

[8]  F. Petraglia,et al.  Low Molecular Weight Heparins (LMWH) and Implications along Pregnancy: a Focus on the Placenta , 2021, Reproductive Sciences.

[9]  Lisha Mou,et al.  The Immune Atlas of Human Deciduas With Unexplained Recurrent Pregnancy Loss , 2021, Frontiers in Immunology.

[10]  Pengyun Qiao,et al.  Uterine natural killer cells and recurrent spontaneous abortion , 2021, American journal of reproductive immunology.

[11]  K. Qu,et al.  Single-cell profiling of the human decidual immune microenvironment in patients with recurrent pregnancy loss , 2021, Cell discovery.

[12]  Q. Tu,et al.  Single-cell Immune Landscape of Human Recurrent Miscarriage , 2021, Genom. Proteom. Bioinform..

[13]  M. Du,et al.  Functional regulation of decidual macrophages during pregnancy. , 2020, Journal of reproductive immunology.

[14]  F. Beneventi,et al.  Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies. , 2020, Rheumatology.

[15]  J. Lieberman,et al.  Decidual NK Cells Transfer Granulysin to Selectively Kill Bacteria in Trophoblasts , 2020, Cell.

[16]  M. Pavlicev,et al.  Endometrial Decidualization: The Primary Driver of Pregnancy Health , 2020, International journal of molecular sciences.

[17]  Susumu Tanaka,et al.  The transcription factor HAND2 up-regulates transcription of the IL15 gene in human endometrial stromal cells , 2020, The Journal of Biological Chemistry.

[18]  J. Brosens,et al.  Recurrent pregnancy loss is associated with a pro-senescent decidual response during the peri-implantation window , 2020, Communications Biology.

[19]  B. Peng,et al.  The association between antiphospholipid antibodies and late fetal loss: A systematic review and meta‐analysis , 2019, Acta obstetricia et gynecologica Scandinavica.

[20]  Liping Jin,et al.  Dynamic Function and Composition Changes of Immune Cells During Normal and Pathological Pregnancy at the Maternal-Fetal Interface , 2019, Front. Immunol..

[21]  W. Dean,et al.  Mechanisms of early placental development in mouse and humans , 2019, Nature Reviews Genetics.

[22]  A. Tincani,et al.  Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies , 2019, Front. Immunol..

[23]  M. Ward,et al.  EULAR recommendations for the management of antiphospholipid syndrome in adults , 2019, Annals of the rheumatic diseases.

[24]  K. McCrae,et al.  Complement in the Pathophysiology of the Antiphospholipid Syndrome , 2019, Front. Immunol..

[25]  Kerstin B. Meyer,et al.  Single-cell reconstruction of the early maternal–fetal interface in humans , 2018, Nature.

[26]  S. Brennecke,et al.  Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem/stromal cells and reduces their production of pro-inflammatory cytokines , 2018, Journal of Molecular Medicine.

[27]  T. Tuschl,et al.  A single-cell survey of the human first-trimester placenta and decidua , 2018, Science Advances.

[28]  D. Isenberg,et al.  Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome , 2018, Journal of autoimmunity.

[29]  S. Sciascia,et al.  Antiphospholipid syndrome , 2018, Nature Reviews Disease Primers.

[30]  G. Mor,et al.  The unique immunological and microbial aspects of pregnancy , 2017, Nature Reviews Immunology.

[31]  K. Conrad,et al.  Emerging role for dysregulated decidualization in the genesis of preeclampsia. , 2017, Placenta.

[32]  O. Chazara,et al.  Maternal allo-recognition of the fetus. , 2017, Fertility and sterility.

[33]  Á. Cadavid Aspirin: The Mechanism of Action Revisited in the Context of Pregnancy Complications , 2017, Front. Immunol..

[34]  Yoon Kyung Choi,et al.  Aspirin prevents TNF‐&agr;‐induced endothelial cell dysfunction by regulating the NF‐&kgr;B‐dependent miR‐155/eNOS pathway: Role of a miR‐155/eNOS axis in preeclampsia , 2017, Free radical biology & medicine.

[35]  J. Brosens,et al.  Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8. , 2016, Molecular human reproduction.

[36]  U. Kayisli,et al.  The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. , 2016, Human reproduction update.

[37]  G. Espinosa,et al.  The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases. , 2015, Autoimmunity reviews.

[38]  L. Chamley,et al.  Histopathology in the placentae of women with antiphospholipid antibodies: A systematic review of the literature. , 2015, Autoimmunity reviews.

[39]  J. Strominger,et al.  Immune mechanisms at the maternal-fetal interface: perspectives and challenges , 2015, Nature Immunology.

[40]  J. Gris,et al.  Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. , 2014, Blood.

[41]  A. Sharkey,et al.  Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. , 2013, The Journal of clinical investigation.

[42]  M. Zygmunt,et al.  Heparin inhibits TNF-α signaling in human endometrial stromal cells by interaction with NF-κB. , 2013, Molecular human reproduction.

[43]  Adrian Erlebacher,et al.  Immunology of the maternal-fetal interface. , 2013, Annual review of immunology.

[44]  Mimi Y. Kim,et al.  Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. , 2012, Arthritis and rheumatism.

[45]  Pojen P. Chen,et al.  Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss. , 2012, Journal of autoimmunity.

[46]  P. Meroni,et al.  In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions. , 2011, Blood.

[47]  M. Khamashta,et al.  First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. , 2011, Blood.

[48]  K. McCrae,et al.  Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factors. , 2011, Blood.

[49]  M. Zygmunt,et al.  Heparin inhibits interferon-γ signaling in human endometrial stromal cells by interference with the cellular binding of interferon-γ. , 2011, Fertility and sterility.

[50]  F. Di Nicuolo,et al.  Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin. , 2007, Human reproduction update.

[51]  L. Poston,et al.  The placental bed in pregnancies complicated by primary antiphospholipid syndrome. , 2006, Placenta.

[52]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[53]  D. Ferrara,et al.  Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. , 2005, Arthritis and rheumatism.

[54]  E. Kruithof,et al.  Aspirin inhibits endothelial cell activation induced by antiphospholipid antibodies , 2004, Journal of thrombosis and haemostasis : JTH.

[55]  E. Kruithof,et al.  NFκB is an Essential Intermediate in the Activation of Endothelial Cells by Anti-β2-Glycoprotein 1 Antibodies , 2002, Thrombosis and Haemostasis.

[56]  N. Sebire,et al.  Biology and pathology of the placenta in relation to antiphospholipid antibody-associated pregnancy failure , 2002, Lupus.

[57]  P. Kaufmann [Development of human placenta]. , 1971, Zeitschrift fur Geburtshilfe und Gynakologie.

[58]  E. Kruithof,et al.  NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies. , 2002, Thrombosis and haemostasis.

[59]  L. Chamley,et al.  Synthesis of beta2 glycoprotein 1 by the human placenta. , 1997, Placenta.